132 related articles for article (PubMed ID: 23799649)
1. Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine.
Li P; Chen S; Jiang Y; Jiang J; Zhang Z; Sun X
Nanotechnology; 2013 Jul; 24(29):295101. PubMed ID: 23799649
[TBL] [Abstract][Full Text] [Related]
2. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
3. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.
White KL; Rades T; Furneaux RH; Tyler PC; Hook S
J Pharm Pharmacol; 2006 Jun; 58(6):729-37. PubMed ID: 16734974
[TBL] [Abstract][Full Text] [Related]
4. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
5. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
Lu Y; Kawakami S; Yamashita F; Hashida M
Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
[TBL] [Abstract][Full Text] [Related]
6. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA
J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071
[TBL] [Abstract][Full Text] [Related]
7. Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes.
Perche F; Gosset D; Mével M; Miramon ML; Yaouanc JJ; Pichon C; Benvegnu T; Jaffrès PA; Midoux P
J Drug Target; 2011 Jun; 19(5):315-25. PubMed ID: 20653408
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
[TBL] [Abstract][Full Text] [Related]
9. [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro].
Sun X; Tian L; Nie Y; Zhang Z; Lu J; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):191-5. PubMed ID: 17333920
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of lipid-protamine-DNA complexes and evaluation of their transfection efficiencies in vitro].
Sun X; Zhang ZR
Yao Xue Xue Bao; 2004 Oct; 39(10):792-6. PubMed ID: 15700818
[TBL] [Abstract][Full Text] [Related]
11. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
[TBL] [Abstract][Full Text] [Related]
12. Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells.
Sun X; Chen S; Han J; Zhang Z
Int J Nanomedicine; 2012; 7():2929-42. PubMed ID: 22745554
[TBL] [Abstract][Full Text] [Related]
13. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route.
Hattori Y; Kawakami S; Nakamura K; Yamashita F; Hashida M
J Pharmacol Exp Ther; 2006 Aug; 318(2):828-34. PubMed ID: 16670348
[TBL] [Abstract][Full Text] [Related]
14. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
Wijagkanalan W; Kawakami S; Takenaga M; Igarashi R; Yamashita F; Hashida M
J Control Release; 2008 Jan; 125(2):121-30. PubMed ID: 18037185
[TBL] [Abstract][Full Text] [Related]
15. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes.
Espuelas S; Thumann C; Heurtault B; Schuber F; Frisch B
Bioconjug Chem; 2008 Dec; 19(12):2385-93. PubMed ID: 19053315
[TBL] [Abstract][Full Text] [Related]
16. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.
Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
Biomaterials; 2010 Oct; 31(30):7813-26. PubMed ID: 20656348
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
Zeng Z; Dai S; Jiao Y; Jiang L; Zhao Y; Wang B; Zong L
Int J Pharm; 2016 Jun; 506(1-2):394-406. PubMed ID: 27106528
[TBL] [Abstract][Full Text] [Related]
18. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor.
Cui Z; Han SJ; Huang L
Pharm Res; 2004 Jun; 21(6):1018-25. PubMed ID: 15212168
[TBL] [Abstract][Full Text] [Related]
19. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
[TBL] [Abstract][Full Text] [Related]
20. Anionic LPD complexes for gene delivery to macrophage: preparation, characterization and transfection in vitro.
Sun P; Zhong M; Shi X; Li Z
J Drug Target; 2008 Nov; 16(9):668-78. PubMed ID: 18982515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
